| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |